Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825791 | Clinical Therapeutics | 2012 | 15 Pages |
Abstract
Based on the findings from this cost-effectiveness analysis, the favorable clinical benefit of escitalopram resulted in a positive health economic benefit in the Netherlands.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Mark J.C. MD, PhD, Mélanie Brignone, Florence PharmD, MSc, Johan A. MD, PhD, Erik MD, PhD,